Dabrafenib and/or Trametinib Rollover Study
Novartis
Novartis
Pfizer
Pfizer
Endeavor Biomedicines, Inc.
Nested Therapeutics, Inc
Ikena Oncology
Eli Lilly and Company
Aminex Therapeutics, Inc.
Deciphera Pharmaceuticals, LLC
Bristol-Myers Squibb
Genexine, Inc.
Polaris Group
Shenzhen BinDeBio Ltd.
BBB-Therapeutics B.V.
GE Healthcare
INSYS Therapeutics Inc
TransMolecular